Charlotte's Web Holdings (CWBHF) Non-Current Assets (2020 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Non-Current Assets came in at $43.6 million in Q1 2026, down 31.95% year-on-year from $64.0 million in Q1 2025, and down 3.01% on a QoQ basis from $44.9 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Non-Current Assets (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 7 years of Non-Current Assets data on file, last reported at $43.6 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 31.95% year-over-year to $43.6 million in Q1 2026; TTM through Mar 2026 was $183.9 million, a 32.65% decrease from a year earlier, with the FY2025 full-year figure at $44.9 million, down 32.42% from the prior year.
- Non-Current Assets for Q1 2026 stood at $43.6 million, down from $44.9 million in the prior quarter.
- Over the last five years, Non-Current Assets for CWBHF reached as high as $83.9 million in Q4 2022 and fell as low as $43.6 million in Q1 2026.
- Historically, Non-Current Assets has averaged $66.8 million across 5 years, with a median of $70.6 million in 2022.
- Across the five-year window, Non-Current Assets gained 20.78% in 2023 and tumbled 33.76% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $83.9 million in 2022, then declined by 11.33% to $74.4 million in 2023, then decreased by 10.64% to $66.5 million in 2024, then slumped by 32.42% to $44.9 million in 2025, then dropped by 3.01% to $43.6 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $43.6 million in Q1 2026, $44.9 million in Q4 2025, and $47.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 43.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.56 Mn |
| Dec 31, 2025 | 44.91 Mn |
| Sep 30, 2025 | 47.13 Mn |
| Jun 30, 2025 | 48.26 Mn |
| Mar 31, 2025 | 64.02 Mn |
| Dec 31, 2024 | 66.46 Mn |
| Sep 30, 2024 | 69.65 Mn |
| Jun 30, 2024 | 72.86 Mn |
| Mar 31, 2024 | 73.52 Mn |
| Dec 31, 2023 | 74.38 Mn |
| Sep 30, 2023 | 80.12 Mn |
| Jun 30, 2023 | 81.73 Mn |
| Mar 31, 2023 | 74.83 Mn |
| Dec 31, 2022 | 83.88 Mn |
| Sep 30, 2022 | 66.34 Mn |
| Jun 30, 2022 | 70.65 Mn |
| Mar 31, 2022 | 73.12 Mn |
| Dec 31, 2021 | 75.71 Mn |
| Dec 31, 2020 | 166.99 Mn |